Protocols
1 protocol(s) meet the specified criteria
Drug: Tremelimumab
Protocol No.TitleStatus
NCI10021-CIRBNCI 10021: A Phase 2 Study of MEDI4736(durvalumab) and Tremelimumab Alone or in Combination with High or Low-Dose Radiation in Metastatic Colorectal and NSCLCOpen